Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis.

Chromatin-based mechanisms offer therapeutic targets in acute myeloid leukemia (AML) that are of great current interest. In this study, we conducted an RNAi-based screen to identify druggable chromatin regulator-based targets in leukemias marked by oncogenic rearrangements of the MLL gene. In this manner, we discovered the H4K16 histone acetyltransferase (HAT) MOF to be important for leukemia cell growth. Conditional deletion of Mof in a mouse model of MLL-AF9-driven leukemogenesis reduced tumor burden and prolonged host survival. RNA sequencing showed an expected downregulation of genes within DNA damage repair pathways that are controlled by MOF, as correlated with a significant increase in yH2AX nuclear foci in Mof-deficient MLL-AF9 tumor cells. In parallel, Mof loss also impaired global H4K16 acetylation in the tumor cell genome. Rescue experiments with catalytically inactive mutants of MOF showed that its enzymatic activity was required to maintain cancer pathogenicity. In support of the role of MOF in sustaining H4K16 acetylation, a small-molecule inhibitor of the HAT component MYST blocked the growth of both murine and human MLL-AF9 leukemia cell lines. Furthermore, Mof inactivation suppressed leukemia development in an NUP98-HOXA9-driven AML model. Taken together, our results establish that the HAT activity of MOF is required to sustain MLL-AF9 leukemia and may be important for multiple AML subtypes. Blocking this activity is sufficient to stimulate DNA damage, offering a rationale to pursue MOF inhibitors as a targeted approach to treat MLL-rearranged leukemias. Cancer Res; 77(7); 1753-62. ©2017 AACR.

[1]  S. Armstrong,et al.  NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. , 2016, Cancer cell.

[2]  S. Armstrong,et al.  Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs. , 2016, Cancer cell.

[3]  S. Armstrong,et al.  Drugging Chromatin in Cancer: Recent Advances and Novel Approaches. , 2015, Molecular cell.

[4]  Yantao Zhao,et al.  hMOF (human males absent on the first), an oncogenic protein of human oral tongue squamous cell carcinoma, targeting EZH2 (enhancer of zeste homolog 2) , 2015, Cell proliferation.

[5]  John G Doench,et al.  DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia , 2015, Nature Medicine.

[6]  Zhen-hua Hu,et al.  Expression of hMOF in different ovarian tissues and its effects on ovarian cancer prognosis. , 2015, Oncology reports.

[7]  S. Armstrong,et al.  AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes. , 2014, Cancer cell.

[8]  Darjus F. Tschaharganeh,et al.  CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma , 2014, Genes & development.

[9]  T. Ludwig,et al.  MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice. , 2014, Cell reports.

[10]  Tõnis Org,et al.  The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis , 2014, Cell reports.

[11]  S. Knapp,et al.  Targeting bromodomains: epigenetic readers of lysine acetylation , 2014, Nature Reviews Drug Discovery.

[12]  R. Conaway,et al.  Crosstalk between NSL Histone Acetyltransferase and MLL/SET Complexes: NSL Complex Functions in Promoting Histone H3K4 Di-Methylation Activity by MLL/SET Complexes , 2013, PLoS genetics.

[13]  Robert A Copeland,et al.  Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. , 2013, Blood.

[14]  Su Chen,et al.  Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer. , 2013, Cellular signalling.

[15]  T. Ludwig,et al.  T-cell-specific deletion of Mof blocks their differentiation and results in genomic instability in mice. , 2013, Mutagenesis.

[16]  Xian-hong Liu,et al.  RNAi screening identifies KAT8 as a key molecule important for cancer cell survival. , 2013, International journal of clinical and experimental pathology.

[17]  Zhaohui S. Qin,et al.  The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. , 2012, Cell stem cell.

[18]  Crispin J. Miller,et al.  The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. , 2012, Cancer cell.

[19]  J. Hess,et al.  The pathogenesis of mixed-lineage leukemia. , 2012, Annual review of pathology.

[20]  T. Pandita,et al.  The role of MOF in the ionizing radiation response is conserved in Drosophila melanogaster , 2012, Chromosoma.

[21]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[22]  Lars Bullinger,et al.  MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. , 2011, Cancer cell.

[23]  Yonghong Xiao,et al.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.

[24]  Dafydd G. Thomas,et al.  Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. , 2011, Blood.

[25]  N. Zeleznik-Le,et al.  Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. , 2010, Cancer research.

[26]  P. Pan,et al.  MOF and H4 K16 Acetylation Play Important Roles in DNA Damage Repair by Modulating Recruitment of DNA Damage Repair Protein Mdc1 , 2010, Molecular and Cellular Biology.

[27]  C. Allis,et al.  Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.

[28]  David J. Chen,et al.  MOF and Histone H4 Acetylation at Lysine 16 Are Critical for DNA Damage Response and Double-Strand Break Repair , 2010, Molecular and Cellular Biology.

[29]  Hui Zhang,et al.  MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. , 2010, Cancer cell.

[30]  Richard A Young,et al.  Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. , 2008, Genes & development.

[31]  Xiaobo Xia,et al.  H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.

[32]  R. Roeder,et al.  30 nm chromatin fibre decompaction requires both H4-K16 acetylation and linker histone eviction. , 2008, Journal of molecular biology.

[33]  A. Voss,et al.  Mof (MYST1 or KAT8) Is Essential for Progression of Embryonic Development Past the Blastocyst Stage and Required for Normal Chromatin Architecture , 2008, Molecular and Cellular Biology.

[34]  Peter Lichter,et al.  The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma , 2008, International journal of cancer.

[35]  T. Ludwig,et al.  The Mammalian Ortholog of Drosophila MOF That Acetylates Histone H4 Lysine 16 Is Essential for Embryogenesis and Oncogenesis , 2007, Molecular and Cellular Biology.

[36]  J. Fisher,et al.  Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. , 2007, Cell stem cell.

[37]  X. Yang,et al.  MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells , 2007, Oncogene.

[38]  M. Pazin,et al.  Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions , 2006, Science.

[39]  William Arbuthnot Sir Lane,et al.  A Human Protein Complex Homologous to the Drosophila MSL Complex Is Responsible for the Majority of Histone H4 Acetylation at Lysine 16 , 2005, Molecular and Cellular Biology.

[40]  P. Lichter,et al.  hMOF Histone Acetyltransferase Is Required for Histone H4 Lysine 16 Acetylation in Mammalian Cells , 2005, Molecular and Cellular Biology.

[41]  Thomas A. Milne,et al.  Physical Association and Coordinate Function of the H3 K4 Methyltransferase MLL1 and the H4 K16 Acetyltransferase MOF , 2005, Cell.

[42]  T. Ludwig,et al.  Involvement of Human MOF in ATM Function , 2005, Molecular and Cellular Biology.

[43]  R. Greenberg.  Telomeres, crisis and cancer. , 2005, Current molecular medicine.

[44]  P. Becker,et al.  Activation of transcription through histone H4 acetylation by MOF, an acetyltransferase essential for dosage compensation in Drosophila. , 2000, Molecular cell.

[45]  L. Pillus,et al.  Yeast SAS silencing genes and human genes associated with AML and HIV–1 Tat interactions are homologous with acetyltransferases , 1996, Nature Genetics.

[46]  M. Greaves.  Infant leukaemia biology, aetiology and treatment. , 1996, Leukemia.

[47]  Michael L. Cleary,et al.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.

[48]  G. Evans,et al.  A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias , 1992, Nature Genetics.

[49]  H. Haisma,et al.  6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site. , 2012, European journal of medicinal chemistry.